Jeff Bedard
Jeff Bedard is a Crown Laboratories and Revance transition leader. His relevance comes from the 2025 period when Crown Laboratories completed its acquisition of Revance Therapeutics and later began operating under the Revance name.
Bedard’s role is acquisition and company-transition context, not Daxxify product-development history. Revance Therapeutics developed Daxxify, while Crown’s acquisition changed the ownership and corporate context around the Revance business.
Role Context
Section titled “Role Context”| Field | Detail |
|---|---|
| Organization context | Crown Laboratories / Revance |
| Public role context | CEO of Revance in Crown’s March 31, 2025 name-transition announcement |
| Industry relevance | Crown acquisition and Revance rebrand transition |
| Relevant company | Revance / Crown Laboratories |
| Relevant brand | Daxxify |
| Market context | Post-acquisition ownership, company naming, and aesthetics portfolio integration |
Career Notes
Section titled “Career Notes”- Crown announced on March 31, 2025 that it would operate under the Revance name following its acquisition of Revance Therapeutics.
- The announcement quoted Bedard as CEO of Revance in the name-transition context.
- The same announcement described Daxxify as part of Revance’s balanced aesthetics portfolio.
- A later October 1, 2025 Revance announcement identified Nadeem Moiz as Chief Executive Officer, placing Bedard’s relevance in the transition period rather than current Revance CEO leadership.
Acquisition Transition Context
Section titled “Acquisition Transition Context”Bedard matters because Crown’s acquisition created a confusing name trail. “Crown Laboratories,” “Revance,” and “Revance Therapeutics” can all appear in searches around Daxxify, but they do not mean the product was newly developed in 2025.
The clean interpretation is that Revance Therapeutics developed Daxxify, Crown acquired Revance in 2025, and the combined company later used the Revance name. That ownership transition does not change Daxxify’s product identity, label, or product-specific unit system.
Activity and Public Context
Section titled “Activity and Public Context”Bedard’s relevance is the Crown acquisition and rebrand bridge. For current Revance executive leadership after October 2025, Nadeem Moiz is the stronger CEO reference.